Target intelligence / Profile preview

Tubulin beta-4A chain (TUBB4A) (TUBB4A)

Target
TUBB4A
Molecular classification
Structural protein, Cytoskeletal protein, GTPase, Enzyme
01

Overview

Tubulin beta-4A chain (TUBB4A) is a structural protein that serves as a fundamental component of microtubules, which are essential for maintaining cellular architecture, facilitating intracellular transport, and enabling chromosome segregation during mitosis. It forms heterodimers with alpha-tubulin, which then polymerize into the hollow tubes that constitute the cytoskeleton. TUBB4A is highly expressed in the central nervous system, particularly in the basal ganglia and cerebellum, where it is critical for the development and maintenance of white matter and myelin. Mutations in the TUBB4A gene are the primary cause of several neurodevelopmental and neurodegenerative disorders, most notably hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) and hereditary whispering dysphonia (DYT4). In the context of oncology, TUBB4A is a target for microtubule-targeting agents (MTAs), including taxanes and vinca alkaloids, which interfere with microtubule dynamics to trigger cell cycle arrest and apoptosis. Furthermore, aberrant expression of TUBB4A has been linked to tumor progression and resistance to chemotherapy in various cancers, such as melanoma and non-small cell lung cancer.

Other names
TUBB4TUBB5TBB4ADystonia 4DYT4Tubulin beta-4A class IVaTubulin beta-4 chain
02

Mechanism of action

Microtubule-targeting agents bind to specific sites on the beta-tubulin subunit to either stabilize (e.g., taxanes) or destabilize (e.g., vinca alkaloids) microtubules, thereby disrupting the dynamic instability required for mitotic spindle formation and leading to cell cycle arrest and apoptosis.

03

Biological functions

Microtubule assemblyMitosisIntracellular transportCell motilityNeuronal developmentMyelination
04

Disease associations

Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)Dystonia type 4 (DYT4)CancerMelanomaLung cancerProstate cancerHereditary spastic paraplegia
05

Safety considerations

Peripheral neuropathyMyelosuppressionDrug resistance (isotype switching)P-glycoprotein mediated efflux
06

Interacting drugs

Paclitaxel

10 more in the full profile.

07

Biomarkers

TUBB4A expression levelsSerum TUBB levelsTUBB4A gene mutations

Beyond the preview

Go deeper on Tubulin beta-4A chain (TUBB4A) (TUBB4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta-4A chain (TUBB4A) (TUBB4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call